Stockscreener 앱 받기
8.93
3.98%
-0.37
시간 외 거래:
8.60
-0.33
-3.70%
전일 마감가:
$9.30
열려 있는:
$9.17
하루 거래량:
848.81K
Relative Volume:
0.72
시가총액:
$242.49M
수익:
$157.75M
순이익/손실:
$-29.73M
주가수익비율:
-7.6983
EPS:
-1.16
순현금흐름:
$-21.00M
1주 성능:
-9.62%
1개월 성능:
-60.42%
6개월 성능:
-30.40%
1년 성능:
-49.89%
1일 변동 폭
$8.835
$9.40
1주일 범위
$8.835
$10.12
52주 변동 폭
$8.04
$24.17
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
명칭
Arcturus Therapeutics Holdings Inc
전화
(858) 900-2660
주소
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
ARCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
8.93 | 252.54M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-24 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-10-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-10-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-05-28 | 개시 | Scotiabank | Sector Outperform |
| 2025-01-28 | 개시 | BTIG Research | Buy |
| 2024-08-12 | 개시 | Leerink Partners | Outperform |
| 2023-12-13 | 개시 | Canaccord Genuity | Buy |
| 2023-07-24 | 개시 | William Blair | Outperform |
| 2023-05-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | 재개 | Wells Fargo | Overweight |
| 2022-11-10 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-11-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-08-10 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | 재개 | Cantor Fitzgerald | Overweight |
| 2022-05-11 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-01-31 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-10 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2021-06-21 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-02-17 | 다운그레이드 | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | 개시 | Wells Fargo | Overweight |
| 2020-12-29 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-12-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | 다운그레이드 | ROTH Capital | Buy → Sell |
| 2020-12-08 | 재확인 | B. Riley Securities | Buy |
| 2020-12-07 | 재확인 | B. Riley Securities | Buy |
| 2020-10-26 | 개시 | Barclays | Overweight |
| 2020-10-06 | 개시 | Citigroup | Buy |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-07-30 | 재개 | ROTH Capital | Buy |
| 2020-07-16 | 개시 | Raymond James | Outperform |
| 2020-07-13 | 개시 | B. Riley FBR | Buy |
| 2020-06-09 | 다운그레이드 | WBB Securities | Buy → Hold |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2020-02-07 | 개시 | Guggenheim | Buy |
| 2020-02-06 | 개시 | Guggenheim | Buy |
| 2019-04-05 | 개시 | H.C. Wainwright | Buy |
| 2018-09-20 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | 개시 | Chardan Capital Markets | Buy |
모두보기
Arcturus Therapeutics Holdings Inc 주식(ARCT)의 최신 뉴스
Ongoing Securities Investigation into Arcturus Therapeutics Holdings Inc. (ARCT)Contact Levi & Korsinsky - ACCESS Newswire
Arcturus Therapeutics (NASDAQ: ARCT) at Guggenheim Nov. 12 & Jefferies Nov. 17–20 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Arcturus Therapeutics Holdings Inc. (ARCT) And Encourages Shareholders to Connect - ACCESS Newswire
Is Arcturus Therapeutics Holdings Inc. stock ready for a breakoutMarket Sentiment Review & Verified Momentum Watchlists - newser.com
Arcturus Therapeutics (ARCT) to Release Earnings on Monday - MarketBeat
How Arcturus Therapeutics Holdings Inc. stock valuations compare to rivalsJuly 2025 Macro Moves & Real-Time Buy Zone Alerts - newser.com
How to use a screener to detect Arcturus Therapeutics Holdings Inc. breakoutsWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Real time scanner hits for Arcturus Therapeutics Holdings Inc. explainedJuly 2025 News Drivers & Risk Adjusted Swing Trade Ideas - newser.com
What MACD signals say about Arcturus Therapeutics Holdings Inc.M&A Rumor & Pattern Based Trade Signal System - newser.com
Can momentum traders help lift Arcturus Therapeutics Holdings Inc.Weekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Ongoing Investigation Into Arcturus Therapeutics Holdings Inc. (ARCT): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire
Protect Your Investment: Contact Levi & Korsinsky About the Arcturus Therapeutics Holdings Inc. (ARCT) Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Arcturus Therapeutics Holdings Inc. (ARCT) And Encourages Investors to Connect - ACCESS Newswire
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline - Yahoo Finance
Arcturus Therapeutics Holdings Inc. stock volume spike explainedTrade Exit Summary & Stepwise Trade Signal Implementation - newser.com
Is Arcturus Therapeutics Holdings Inc. stock cheap at current valuationJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-11-03 05:43:35 - newser.com
Can Arcturus Therapeutics Holdings Inc. stock beat market expectations this quarterEarnings Recap Report & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Arcturus Therapeutics Holdings Inc.2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
What candlestick patterns are forming on Arcturus Therapeutics Holdings Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-02 01:11:00 - newser.com
How Arcturus Therapeutics Holdings Inc. stock compares to market leadersVolume Spike & Advanced Technical Signal Analysis - newser.com
How to forecast Arcturus Therapeutics Holdings Inc. trends using time seriesQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Published on: 2025-11-01 04:30:36 - newser.com
Is Arcturus Therapeutics Holdings Inc. stock attractive for income investorsJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Sumitomo Mitsui Trust Group, Inc. Expands Stake in Arcturus Ther - GuruFocus
Potential Securities Fraud: Levi & Korsinsky Investigates Arcturus Therapeutics Holdings Inc. (ARCT) - ACCESS Newswire
High Growth Tech Stocks In US With Promising Potential - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation | NDAQ:ARCT | Press Release - Stockhouse
How currency fluctuations impact Arcturus Therapeutics Holdings Inc. stockPortfolio Update Report & Proven Capital Preservation Methods - newser.com
What technical models suggest about Arcturus Therapeutics Holdings Inc.’s comebackJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Arcturus Therapeutics Holdings (ARCT) Price Target Decreased by 30.87% to 45.67 - MSN
Arcturus Therapeutics Holdings Inc. (ARCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Arcturus Therapeutics Holdings Inc. (ARCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-30 03:05:20 - newser.com
Arcturus Therapeutics Holdings Inc. $ARCT Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Arcturus Therapeutics Holdings Inc (ARCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):